Answers are grounded in this paper and cite their sources.
Background/Objectives: The relationship between pancreatic cancer (PC) and diabetes mellitus (DM) is complex. The aim was to investigate the prevalence of DM in patients with PC diagnosed within two years of the PC diagnosis (NODM) and in patients diagnosed more than two years previously (LSDM), and to determine the clinical profile and prognosis of these patients. Methods: A retrospective case–control study of patients diagnosed with PC drawn from the Lleida Population-Based Cancer Registry (Spain). Data were collected from the electronic health records. The cases were patients with PC who had a history of diabetes of ≤2 years (NODM) or >2 years (LSDM), and the controls were patients with PC who did not have diabetes. The factors associated with NODM and LSDM were determined using adjusted odds ratios (aOR) via logistic regression models. Results: A total of 574 patients with PC were studied; 40.2% were diabetic (cases) and 59.8% were non-diabetic (controls). Of the cases, 24.7% had NODM and 75.3% had LSDM. The group with NODM was associated with the 65–74 age group (OR 3.09; 95% CI 1.47–6.49) and had higher levels of transaminase abnormalities (p < 0.001) and hypertension (OR 13.50; 95% CI 3.33–54.8). The group with LSDM was associated with being aged 74 years or older (aOR 2.38; 95% CI 1.44–3.91), being overweight (aOR 1.96; 95% CI 1.15–3.35) and having coronary heart disease (aOR 2.17; 95% CI 1.29–3.66). The mean survival time was shorter in the LSDM group (315 days) than in the NODM group (433 days) (p < 0.017). Conclusions: Co-diagnosis of PC and DM is common. DM and its comorbidities exhibit different characteristics depending on the time of diagnosis, prior to the onset of PC. These differences may help to identify patients who could benefit from monitoring strategies.
No takes yet. Share an insight, caveat, or question.
Fuentes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: